SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    G. H. Petit, T. T. Olsson, P. Brundin, Review: The future of cell therapies and brain repair: Parkinson's disease leads the way, Neuropathology and Applied Neurobiology, 2014, 40, 1
  2. 2
    Olle Lindvall, Developing dopaminergic cell therapy for Parkinson's disease—give up or move forward?, Movement Disorders, 2013, 28, 3
  3. 3
    V. Dietz, Neurological Rehabilitation, 2013,

    CrossRef

  4. 4
    Pierre Pollak, Brain Stimulation, 2013,

    CrossRef

  5. 5
    Neil M. Issar, Joseph S. Neimat, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  6. 6
    Neil Issar, Joseph Neimat, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  7. 7
    Joanna García, Thomas Carlsson, Máté Döbrössy, Guido Nikkhah, Christian Winkler, Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model, Brain Research, 2012, 1470, 119

    CrossRef

  8. 8
    Gaynor A. Smith, Ludivine S. Breger, Emma L. Lane, Stephen B. Dunnett, Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats, Neuropharmacology, 2012, 63, 5, 818

    CrossRef

  9. 9
    Emma L. Lane, Christian Winkler, Functional Neural Transplantation III - Primary and Stem Cell Therapies for Brain Repair, Part I, 2012,

    CrossRef

  10. 10
    Olle Lindvall, Anders Björklund, Cell Therapeutics in Parkinson’s Disease, Neurotherapeutics, 2011, 8, 4, 539

    CrossRef

  11. 11
    Sean C Dyson, Roger A Barker, Cell-based therapies for Parkinson’s disease, Expert Review of Neurotherapeutics, 2011, 11, 6, 831

    CrossRef

  12. 12
    Stephen B. Dunnett, Anne E. Rosser, Clinical translation of cell transplantation in the brain, Current Opinion in Organ Transplantation, 2011, 16, 6, 632

    CrossRef

  13. 13
    Joanna García, Thomas Carlsson, Máté Döbrössy, Guido Nikkhah, Christian Winkler, Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation, Experimental Neurology, 2011, 232, 2, 270

    CrossRef

  14. 14
    Marios Politis, Wolfgang H. Oertel, Kit Wu, Niall P. Quinn, Oliver Pogarell, David J. Brooks, Anders Bjorklund, Olle Lindvall, Paola Piccini, Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio, Movement Disorders, 2011, 26, 11
  15. 15
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  16. 16
    Emma L. Lane, Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia, 2011,

    CrossRef

  17. 17
    Li Rebekah Feng, Kathleen A. Maguire-Zeiss, Gene Therapy in Parkinsonʼs Disease, CNS Drugs, 2010, 24, 3, 177

    CrossRef

  18. 18
    EL Lane, GA Smith, Understanding graft-induced dyskinesia, Regenerative Medicine, 2010, 5, 5, 787

    CrossRef

  19. 19
    Emma L. Lane, Anders Björklund, Stephen B. Dunnett, Christian Winkler, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  20. 20
    Emma Louise Lane, Patrik Brundin, M. Angela Cenci, Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease, Neurobiology of Disease, 2009, 35, 1, 42

    CrossRef

  21. 21
    Olle Lindvall, Zaal Kokaia, Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease, Trends in Pharmacological Sciences, 2009, 30, 5, 260

    CrossRef

  22. 22
    S. Elizabeth Zauber, Christopher G. Goetz, Dyskinesias in Parkinsonian Syndromes,